Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Bufexamac | 2438-72-4 | MFCD00078936 | 98.0% | 1 ML
SDP

Supplier:  Medchemexpress LLC HYB049410MM/1ML

Encompass_Preferred

Bufexamac is a selective Ⅱb HDAC (HDAC6, HDAC10) and LTA4H dual inhibitor, with Kds of 0.53 μM and 0.22 μM for HDAC6 and HDAC10. It is also a nonsteroidal anti-inflammatory drug. This product is for research use only.

  • Acts as a dual inhibitor for HDAC6, HDAC10, and LTA4H with specific Kd values.
  • Functions as a nonsteroidal anti-inflammatory drug.
  • Inhibits the secretion of IFN-α in peripheral blood mononuclear cells.
  • Inhibits HDAC10 to block autophagic flux in BE(2)-C cells.
  • Inhibits neutrophil chemotaxis by inhibiting LTA4H-mediated endogenous LTB4 biosynthesis.
  • Inhibits lysine deacetylases (KDACs) at lower concentrations.
  • Ameliorates LPS-induced acute lung injury in mice by targeting LTA4H.
  • Did not cause untoward systemic or local effects in healthy horses during intra-articular injections.

Catalog No. 50-004-09452


May include imposed supplier surcharges.
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.